Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Community Health Equity Res Policy ; 44(1): 109-121, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37724033

RESUMO

Poor nutrition compromises the capacity of women to perform their vital roles as mothers and productive workers in their families, communities and society. Using a conceptual framework developed by the United Nations Children's Fund, this study determines individual-, household- and community-level factors associated with the nutritional status of Nigerian women of reproductive age. A secondary analysis of pooled data from the Nigeria Demographic and Health Survey (NDHS) for 2003, 2008, 2013 and 2018 was conducted involving 82,734 non-pregnant women aged 15-49 years. Multinomial logistic regression was used to determine predictors of nutritional status. Study results show that a significant proportion of the women had poor nutritional status; the prevalence of underweight, overweight and obesity were 12.1%, 16.8% and 7.2% respectively. Statistically significant factors associated with poor nutritional status were found at all three levels, highlighting the need for effective multidimensional, multisectoral policy interventions to address the double burden of malnutrition among women in Nigeria.


Assuntos
Desnutrição , Estado Nutricional , Feminino , Humanos , População Negra , Desnutrição/epidemiologia , Mães , Nigéria/epidemiologia , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade
2.
SAGE Open Med ; 11: 20503121231158220, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36923111

RESUMO

Objectives: To compare Premaquick biomarkers (combined insulin-like growth-factor binding protein 1 and interleukin-6) and cervical length measurement via transvaginal ultrasound for pre-induction cervical evaluation at term among pregnant women. Methods: A randomized clinical trial of consenting pregnant women at the Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. The women were randomized equally into Premaquick group (n = 36) and transvaginal ultrasound group (n = 36). The cervix was adjudged 'ripe' if the Premaquick test was positive or if the trans-vaginal measured cervical length was less than 28 mm. The primary outcome measures were the proportions of women who needed prostaglandin analogue for cervical ripening and the proportion that achieved vaginal delivery after induction of labour. The trial was registered in Pan African clinical trial registry (PACTR) registry with approval number PACTR202001579275333. Results: The baseline characteristics were similar between the two groups (p > 0.05). There was no statistically significant difference between the two groups in terms of proportion of women that required prostaglandins for pre-induction cervical ripening (41.7 versus 47.2%, p = 0.427), vaginal delivery (77.8 versus 80.6%, p = 0.783), mean induction to delivery interval (22.9 ± 2.81 h versus 24.04 ± 3.20 h, p = 0.211), caesarean delivery (22.2 versus 19.4%, p = 0.783), proportion of neonate with birth asphyxia (8.30 versus 8.30%, p = 1.00) and proportion of neonate admitted into special care baby unit (16.7 versus 13.9%, p = 0.872). Subgroup analysis of participants with 'ripe' cervix at initial pre-induction assessment showed that the mean induction to active phase of labour interval and mean induction to delivery interval were significantly shorter in Premaquick than transvaginal ultrasound group. Conclusion: Pre-induction cervical assessment at term with either Premaquick biomarkers or transvaginal ultrasound for cervical length is effective, objective and safe with similar and comparable outcome. However, when compared with women with positive transvaginal ultrasound at initial assessment, women with positive Premaquick test at initial assessment showed a significantly shorter duration of onset of active phase of labour and delivery of baby following induction of labour.

3.
Biomed Res Int ; 2022: 2442338, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36158889

RESUMO

Background: Fetal fibronectin is a useful biomarker in the diagnosis and management of preterm labour. Objectives: To evaluate the relationship between cervical fetal fibronectin and preterm delivery and the association between cervical fetal fibronectin level and gestational age at delivery. Materials and Methods: A prospective cohort study was performed in a tertiary hospital in Nigeria, involving equal number of pregnant women with (96) and without (96) preterm labour. Fetal fibronectin assay was done using solid-phase immunogold assay. The data were analysed using IBM SPSS version 24. Descriptive and inferential statistical analyses were done. The level of significance was p-value <0.05. Results: Less than half (47.9%) of the women in the study group had preterm delivery while 13.09% of the women in the control group delivered preterm. Fetal fibronectin test had a sensitivity, specificity, positive predictive value and negative predictive value of 78%, 86.5%, 71.9%, and 89.0%, respectively, a positive likelihood ratio and negative likelihood ratio of 5.76(95% CI, 3.67 - 9.64) and 0.26(95% CI, 0.16 - 0.41), respectively. Conclusion: The findings in our study value of fetal fibronectin in predicting preterm delivery. Its use will support less intervention for patients with negative results.


Assuntos
Trabalho de Parto Prematuro , Nascimento Prematuro , Biomarcadores , Colo do Útero , Estudos de Coortes , Ensaio de Imunoadsorção Enzimática , Feminino , Fibronectinas , Humanos , Recém-Nascido , Nigéria , Trabalho de Parto Prematuro/diagnóstico , Valor Preditivo dos Testes , Gravidez , Nascimento Prematuro/diagnóstico , Estudos Prospectivos , Sensibilidade e Especificidade
4.
Int J Gynaecol Obstet ; 137(3): 345-349, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28236647

RESUMO

OBJECTIVE: To determine the effect of on-site training on the accuracy of blood loss estimation in a simulated obstetrics environment. METHODS: In a tertiary hospital in Nigeria, clinical scenarios were created in April 2013 using known blood volumes in an objective structured clinical examination fashion. Doctors and nurses who worked in the obstetrics unit observed and recorded the blood volume at different clinical stations (first study stage). Subsequently, the actual amount of blood was revealed, followed by on-site training on the volume capacities of the study instruments. Three weeks later, the second stage of the study was performed like the first stage but using different amounts of blood for all stations. The differences in the mean errors of blood loss estimation between the two stages were determined. RESULTS: The analysis included 144 healthcare providers who completed both stages of the study. There were significant differences in the mean error of blood loss estimation before and after the training session for the following stations: delivery bed (P<0.001), sanitary pad 1 (P=0.001), sanitary pad 2 (P=0.001), delivery pad (P=0.001), floor (P<0.001), and laparotomy pad (P=0.001). CONCLUSION: Periodic education by simulation using clinical scenarios could improve the accuracy of visual blood loss estimation.


Assuntos
Volume Sanguíneo , Pessoal de Saúde/educação , Obstetrícia/educação , Hemorragia Pós-Parto/diagnóstico , Treinamento por Simulação , Competência Clínica , Educação , Avaliação Educacional , Feminino , Pessoal de Saúde/normas , Humanos , Nigéria , Obstetrícia/normas , Estudos Prospectivos , Reprodutibilidade dos Testes
5.
Int J Gynaecol Obstet ; 131(2): 174-7, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26283223

RESUMO

OBJECTIVE: To determine women's perceptions and expectations of focused prenatal care visits. METHODS: The present questionnaire-based, cross-sectional survey was performed among pregnant women in their third trimester attending two tertiary health centers in southern Nigeria between January and March 2012. Obstetric data, histories, and information on preferences for prenatal visits were obtained using questionnaires. RESULTS: A total of 353 questionnaires were appropriately completed. Among 277 participants who stated a preference for the number of prenatal care visits, 241 (87.0%) reported a preference of more than four. Among 203 parous women, 132 (65.0%) had no previous negative obstetric experience. Only previous stillbirth (odds ratio [OR] 2.67, 95% confidence interval [CI] 1.05-6.77; P = 0.039) among multiparous women, and HIV/AIDS (OR 0.27, 95% CI 0.06-1.17; P = 0.048) among all women were significantly associated with a preference for more prenatal visits. CONCLUSION: Previous negative obstetric experiences did not generally affect preference for prenatal visits. However, pregnant women expressed dissatisfaction with a reduced number of visits.


Assuntos
Visita a Consultório Médico , Preferência do Paciente , Terceiro Trimestre da Gravidez/psicologia , Cuidado Pré-Natal/psicologia , Centros de Atenção Terciária , Adulto , Estudos Transversais , Feminino , Humanos , Nigéria , Gravidez , Cuidado Pré-Natal/métodos , Inquéritos e Questionários , Adulto Jovem
6.
Int J Gynaecol Obstet ; 127(1): 10-4, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24994495

RESUMO

OBJECTIVE: To identify microbes prevalent in the genital tract of pregnant women with preterm premature rupture of membranes (PPROM) and to assess the susceptibility of the microbial isolates to a range of antibiotics to determine appropriate antibiotics for treating cases of PPROM in resource-limited settings. METHODS: A prospective cross-sectional study was undertaken involving women with (n=105) and without (n=105) a confirmed diagnosis of PPROM admitted to Nnamdi Azikiwe University Teaching Hospital, southeast Nigeria, between January 1, 2011, and April 30, 2013. Endocervical swabs were collected from all participants and examined microbiologically. Antibiotic sensitivity testing was performed using Kirby-Bauer disk diffusion. RESULTS: Streptococcus spp., Staphylococcus aureus, and Escherichia coli were significantly more prevalent among women with PPROM than among those without PPROM (P<0.01). Among the antibiotics considered safe to use during pregnancy, the bacteria were most sensitive to ampicillin-sulbactam, cefixime, cefuroxime, and erythromycin. CONCLUSION: For the first 48hours, women with PPROM should receive an intravenous dose combining ampicillin-sulbactam, cefixime, cefuroxime, or erythromycin with metronidazole followed by oral administration of the chosen antibiotic combination to complete a 7-day course.


Assuntos
Países em Desenvolvimento , Ruptura Prematura de Membranas Fetais/microbiologia , Genitália Feminina/microbiologia , Adulto , Antibacterianos/uso terapêutico , Estudos Transversais , Feminino , Humanos , Testes de Sensibilidade Microbiana , Gravidez , Complicações Infecciosas na Gravidez/prevenção & controle , Estudos Prospectivos
7.
Int J Gynaecol Obstet ; 124(1): 67-71, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24365208

RESUMO

OBJECTIVE: To compare the efficacy and adverse effects of ergometrine and oxytocin given intramuscularly for the prevention of postpartum hemorrhage during the third stage of labor. METHODS: The study included women with a singleton pregnancy of at least 28 weeks' gestation who had a vaginal delivery. High-risk pregnancies were excluded. Oxytocin (10 IU) or ergometrine (0.5mg) were administered intramuscularly in a blinded pattern immediately after delivery of the infant. An intention-to-treat analysis was performed. RESULTS: Postpartum blood loss (301.8 ± 109.2 mL versus 287.1 ± 84.4 mL, P=0.011) and packed cell volume (30.7 ± 1.7% versus 31.6 ± 2.0%; Z=0.00; P=0.008) were considerably reduced among parturients who received intramuscular ergometrine. The rates of therapeutic oxytocics use, blood transfusion, placental retention, and manual removal of the placenta were significantly higher in the oxytocin group. No significant differences between the groups were observed in terms of adverse effects, with the exception of diastolic hypertension, which was more common in the ergometrine group (odds ratio, 0.00; 95% confidence interval, 0.00-0.75; P=0.007). CONCLUSION: Intramuscular ergometrine is superior to intramuscular oxytocin in averting postpartum hemorrhage during the third stage of labor. There are no significant risks of adverse effects except for diastolic hypertension.


Assuntos
Ergonovina/uso terapêutico , Ocitócicos/uso terapêutico , Ocitocina/uso terapêutico , Hemorragia Pós-Parto/prevenção & controle , Adolescente , Adulto , Método Duplo-Cego , Ergonovina/farmacologia , Feminino , Humanos , Injeções Intramusculares , Terceira Fase do Trabalho de Parto/efeitos dos fármacos , Pessoa de Meia-Idade , Ocitócicos/farmacologia , Ocitocina/farmacologia , Gravidez , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA